Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AMRX | Class A Common Stock | Sale | -$56.9K | -6.77K | -7.25% | $8.41 | 86.6K | Nov 21, 2024 | Direct | F1 |
transaction | AMRX | Class A Common Stock | Sale | -$277K | -33.2K | -38.36% | $8.34 | 53.4K | Nov 22, 2024 | Direct | F2 |
Id | Content |
---|---|
F1 | The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.38 to $8.47 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote. |
F2 | The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 per share to $8.41 per share, inclusive. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |